BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development

April 11, 2017

What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of the leading global rare disease patient advocacy organization, and the impact patient advocacy groups are making on rare disease research.

 


EBD Group is committed to the rare disease community. To further partnering and collaboration opportunities between leaders from patient advocacy groups, industry, academia and government, the inaugural Cell & Gene Exchange event will be held in Washington, DC May 22–23, 2017. 

Previous Video
BIO-Europe Spring® 2017: Commercializing cell and gene therapies
BIO-Europe Spring® 2017: Commercializing cell and gene therapies

New business models for clinical development and manufacturing require strategic partnerships among researc...

Next Video
BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets
BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets

With the Latin American vaccines market forecast to more than quadruple in size from just over USD 150 mill...